Loading clinical trials...
Loading clinical trials...
GOAL-Post is comprised of two studies that will help refine recommendations for the duration of secondary prophylaxis for children diagnosed with latent RHD, which is currently not known
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
NCT05991219 · Rheumatic Heart Disease
NCT04936815 · Valvular Heart Disease, Rheumatic Heart Disease, and more
NCT04575857 · Rheumatic Heart Disease, Valvular Disease
NCT07146048 · Rheumatic Heart Disease
NCT05502042 · Rheumatic Heart Disease
Uganda Heart Institute
Kampala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions